Filing Flows › Comparisons › AXSM vs TGTX
Axsome Therapeutics vs TG Therapeutics: AXSM and TGTX compared
Axsome Therapeutics is the larger company: $260M of revenue in its latest quarter (Q3 2026) against $240M for TG Therapeutics (Q2 2026). TG Therapeutics is growing faster (+70% against +52% a year earlier). TG Therapeutics is more profitable, with an operating margin of 9.0% against -4.3%.
Where the money goes: AXSM and TGTX
Axsome Therapeutics (AXSM) · Q3 2026
Axsome Therapeutics, Q3 2026: revenue $260M (+52% year over year), operating margin -4.3%, net loss $12.9M, operating cash flow −$9.5M. The chart follows the revenue to costs, profit and cash.
TG Therapeutics (TGTX) · Q2 2026
TG Therapeutics, Q2 2026: revenue $240M (+70% year over year), operating margin 9.0%, net earnings $7.8M, operating cash flow $39.3M. The chart follows the revenue to costs, profit and cash.
| Axsome Therapeutics (AXSM) | TG Therapeutics (TGTX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $260M | $240M |
| Revenue growth, Y/Y | +52% | +70% |
| Operating margin | -4.3% | 9.0% |
| Net earnings | −$12.9M | $7.8M |
| Net margin | -5.0% | 3.2% |
| Operating cash flow | −$9.5M | $39.3M |
| Free cash flow | — | $39.0M |
| Market value | $8.8B | $8.7B |
| P/E | — | 19.7× |
| Analysts’ mean target | $265.86 | $69.71 |
Where the revenue comes from
Axsome Therapeutics
- Product: $250M (96%)
- Royalty and Milestone Revenue: $9.7M (4%)
TG Therapeutics
- Product: $236M (98%)
- License: $4.5M (2%)
Questions
Which is bigger, Axsome Therapeutics or TG Therapeutics?
Axsome Therapeutics is the larger company: $260M of revenue in its latest quarter (Q3 2026) against $240M for TG Therapeutics (Q2 2026).
Is Axsome Therapeutics or TG Therapeutics growing faster?
TG Therapeutics is growing faster (+70% against +52% a year earlier).
Which is more profitable, Axsome Therapeutics or TG Therapeutics?
TG Therapeutics is more profitable, with an operating margin of 9.0% against -4.3%.
More: Axsome Therapeutics earnings · how Axsome Therapeutics makes money · TG Therapeutics earnings · how TG Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Aug 5, 2026). Fiscal quarters can end on different dates. Not investment advice.